About Jubilant Ingrevia Limited
Data last updated: 09 January 2026
Jubilant Ingrevia Limited is a public limited company based in District Amroha, Uttar Pradesh, India. It specialises in industrial chemicals, a part of the broader chemicals and materials sector. Incorporated on 23 October 2019, the company has been in operation for over 7 years.
Registered with ROC Kanpur under CIN L24299UP2019PLC122657. Listed on BSE: 543271 and NSE: JUBLINGREA.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹15.93 Cr. Formerly known as Jubilant Lsi Limited. It is led by directors including Aashti Bhartia and Siraj Azmat Chaudhry.
Last AGM: 29 August 2025. Financial statements filed for year ended 31 March 2025. Office: Bhartiagram Gajraula, District Amroha, Uttar Pradesh, India – 244223.
As per the financials filed for FY 2025, the company reported a revenue of ₹4,215.43 Cr, a growth of 1% compared to the previous year.
The company has a workforce of approximately 2,186 employees as per the latest available data. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Jubilant Ingrevia. As per MCA filings, the company has open charges of ₹2,220 Cr and satisfied charges of ₹235 Cr on record.
For more details, the company can be reached via its website jubilantingrevia.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressBhartiagram Gajraula, District Amroha, Uttar Pradesh, India – 244223
-
IndustryChemicals and Materials, Industrial Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has one previous CIN (Corporate Identification Number): U24299UP2019PLC122657. The current CIN is L24299UP2019PLC122657, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24299UP2019PLC122657 | Current |
| U24299UP2019PLC122657 | Previous |
Associated Brands with Jubilant Ingrevia Limited
Jubilant Ingrevia Limited operates one associated brand: Jubilant Ingrevia. These brands represent Jubilant Ingrevia Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Key ingredients for health and nutrition solutions are manufactured. | jubilantingrevia.com |
Competitors & Alternatives of Jubilant Ingrevia Limited
Brands and companies operating in the same space as Jubilant Ingrevia Limited include Abzena, Syngene, Grand River Aseptic Manufacturing and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Provider of antibody discovery, cell line development, and bio analytics services | Cambridge, United Kingdom, United Kingdom | 2001 |
|
|
Provider of contract research and manufacturing services for both small molecules and biologics | Bengaluru, India, India | 1993 |
|
|
Sterile parenteral CDMO services for development and manufacturing are offered. | Grand Rapids, United States, United States | 2010 |
|
|
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry | Durham, United States, United States | 1974 |
|
|
Developer of biosimilars, vaccines and natural products | Ambala, India, India | 1984 |
|
|
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate | Mumbai, India, India | 1984 |
|
|
Provides enabling tools and services in the life sciences research and bio-production industries | San Diego, United States, United States | 2014 |
|
|
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | Belmont, United States, United States | 2009 |
|
|
Finished formulations, APIs, and monoclonal antibodies are developed and manufactured. | Madrid, Spain, Spain | 1977 |
Business Activity of Jubilant Ingrevia Limited
Jubilant Ingrevia Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Jubilant Ingrevia Limited
Jubilant Ingrevia Limited is audited by Walker Chandiok & Co LLP (ICAI peer reviewed, certificate valid till 2028-05-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Walker Chandiok & Co LLP (ICAI peer reviewed, certificate valid till 2028-05-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Jubilant Ingrevia Limited
Jubilant Ingrevia Limited is currently managed by 16 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of Jubilant Ingrevia Limited FY 2026 filings available
Jubilant Ingrevia Limited reported revenue of ₹4,388.07 Cr (up 5.04% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹4,388.07 Cr | ₹4,177.61 Cr | ₹4,135.8 Cr | ₹4,772.69 Cr | ₹4,949.36 Cr | ₹684.13 Cr |
| Other Income | ₹40.53 Cr | ₹37.82 Cr | ₹35.3 Cr | ₹33.37 Cr | ₹31.49 Cr | ₹2.6 Cr |
| Total Income | ₹4,428.6 Cr | ₹4,215.43 Cr | ₹4,171.1 Cr | ₹4,806.06 Cr | ₹4,980.85 Cr | ₹686.73 Cr |
| Cost of Materials Consumed | ₹2,104.62 Cr | ₹2,050.28 Cr | ₹2,040.34 Cr | ₹2,547.76 Cr | ₹2,798.13 Cr | ₹363.48 Cr |
| Purchases of Stock-in-Trade | ₹149.04 Cr | ₹56.81 Cr | ₹49.1 Cr | ₹161.55 Cr | ₹141.07 Cr | ₹15.98 Cr |
| Changes in Inventories | ₹41.11 Cr | ₹18 Lakh | ₹53.14 Cr | -₹127.74 Cr | -₹145.07 Cr | -₹9.51 Cr |
| Employee Benefit Expense | ₹425.61 Cr | ₹418.05 Cr | ₹383.95 Cr | ₹343.48 Cr | ₹327.28 Cr | ₹49.02 Cr |
| Finance Costs | ₹49.12 Cr | ₹55.64 Cr | ₹52.66 Cr | ₹21.58 Cr | ₹30.94 Cr | ₹7.33 Cr |
| Depreciation & Amortisation | ₹175.48 Cr | ₹157.63 Cr | ₹136.17 Cr | ₹122.18 Cr | ₹123.39 Cr | ₹22.06 Cr |
| Other Expenses | ₹1,100.65 Cr | ₹1,133.21 Cr | ₹1,188.15 Cr | ₹1,300.5 Cr | ₹996.12 Cr | ₹148.04 Cr |
| Total Expenses | ₹4,045.63 Cr | ₹3,871.8 Cr | ₹3,903.51 Cr | ₹4,369.31 Cr | ₹4,271.86 Cr | ₹596.4 Cr |
| Profit Before Exceptional Items & Tax | ₹382.97 Cr | ₹343.63 Cr | ₹267.59 Cr | ₹436.75 Cr | ₹708.99 Cr | ₹90.33 Cr |
| Exceptional Items | -₹13.04 Cr | ₹0 | ₹0 | -₹4 Lakh | ₹0 | -₹12.94 Cr |
| Profit Before Tax | ₹369.93 Cr | ₹343.63 Cr | ₹267.59 Cr | ₹436.71 Cr | ₹708.99 Cr | ₹77.39 Cr |
| Total Tax Expense | ₹91.84 Cr | ₹92.44 Cr | ₹84.72 Cr | ₹129.21 Cr | ₹232.23 Cr | ₹23.03 Cr |
| Net Profit | ₹277.91 Cr | ₹251.17 Cr | ₹182.89 Cr | ₹307.5 Cr | ₹476.71 Cr | ₹54.36 Cr |
| attributable to Owners | ₹277.91 Cr | ₹251.17 Cr | ₹182.89 Cr | ₹307.5 Cr | ₹476.71 Cr | ₹54.36 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | - | - |
| Other Comprehensive Income | ₹20.32 Cr | ₹1.78 Cr | ₹3.51 Cr | ₹2.4 Cr | ₹95.58 Cr | ₹4.98 Cr |
| Total Comprehensive Income | ₹298.23 Cr | ₹252.95 Cr | ₹186.4 Cr | ₹309.9 Cr | ₹572.29 Cr | ₹59.34 Cr |
| EBITDA (computed) | ₹607.57 Cr | ₹556.9 Cr | ₹456.42 Cr | ₹580.51 Cr | ₹863.32 Cr | ₹119.72 Cr |
| Basic EPS | ₹17.59 | ₹15.89 | ₹11.56 | ₹19.34 | ₹29.98 | ₹20.78 |
| Diluted EPS | ₹17.51 | ₹15.84 | ₹11.55 | ₹19.33 | ₹29.97 | ₹20.78 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹5,483.73 Cr | ₹5,031.77 Cr | ₹4,731.89 Cr | ₹4,258.88 Cr |
| Non-current Assets | ₹3,437.35 Cr | ₹3,178.54 Cr | ₹2,951.99 Cr | ₹2,440.88 Cr |
| Current Assets | ₹2,046.38 Cr | ₹1,853.23 Cr | ₹1,779.9 Cr | ₹1,818 Cr |
| Property, Plant & Equipment | ₹3,148.41 Cr | ₹2,557.79 Cr | ₹2,477.72 Cr | ₹1,787.8 Cr |
| Inventories | ₹879.96 Cr | ₹943.42 Cr | ₹941.3 Cr | ₹1,035.11 Cr |
| Trade Receivables | ₹782.54 Cr | ₹607.13 Cr | ₹571.97 Cr | ₹510.89 Cr |
| Cash & Equivalents | ₹188.47 Cr | ₹69.36 Cr | ₹78.78 Cr | ₹72.73 Cr |
| Equity (Net Worth) | ₹3,126.22 Cr | ₹2,927.08 Cr | ₹2,737.47 Cr | ₹2,666.23 Cr |
| Equity Share Capital | ₹15.77 Cr | ₹15.81 Cr | ₹15.8 Cr | ₹15.9 Cr |
| Borrowings (Non-current) | ₹329.74 Cr | ₹368.27 Cr | ₹425.57 Cr | ₹150 Cr |
| Borrowings (Current) | ₹462.07 Cr | ₹395.51 Cr | ₹307.43 Cr | ₹246.73 Cr |
| Total Debt (computed) | ₹791.81 Cr | ₹763.78 Cr | ₹733 Cr | ₹396.73 Cr |
| Current Liabilities | ₹1,591.71 Cr | ₹1,401 Cr | ₹1,286.08 Cr | ₹1,179.58 Cr |
| Total Liabilities | ₹2,357.51 Cr | ₹2,104.69 Cr | ₹1,994.42 Cr | ₹1,592.65 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹524.27 Cr | ₹508.09 Cr | ₹429.98 Cr | ₹462.46 Cr | ₹452.74 Cr |
| Investing Cash Flow | -₹275.93 Cr | -₹392.8 Cr | -₹568.78 Cr | -₹471.89 Cr | -₹71.86 Cr |
| Financing Cash Flow | -₹155.47 Cr | -₹128.76 Cr | ₹144.13 Cr | ₹41.6 Cr | -₹417.75 Cr |
| Capital Expenditure | ₹299.36 Cr | ₹365.78 Cr | ₹568.37 Cr | ₹481.39 Cr | ₹230.15 Cr |
| Free Cash Flow (computed) | ₹224.91 Cr | ₹142.31 Cr | -₹138.39 Cr | -₹18.93 Cr | ₹222.59 Cr |
| Dividends Paid | ₹79.25 Cr | ₹79.77 Cr | ₹78.62 Cr | ₹79.31 Cr | ₹45.15 Cr |
| Net Change in Cash | ₹119.04 Cr | -₹9.42 Cr | ₹6.05 Cr | ₹35.12 Cr | -₹35.73 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,178.65 Cr | ₹1,050.99 Cr | ₹1,120.73 Cr | ₹1,037.95 Cr | ₹1,051.26 Cr | ₹1,056.77 Cr | ₹1,045.24 Cr | ₹1,024.34 Cr | ₹1,074.44 Cr | ₹966.4 Cr | ₹1,019.94 Cr | ₹1,075.02 Cr |
| Other Income | ₹9.31 Cr | ₹9.42 Cr | ₹10.81 Cr | ₹11.22 Cr | ₹8.36 Cr | ₹9.43 Cr | ₹10.46 Cr | ₹9.57 Cr | ₹9.5 Cr | ₹8.78 Cr | ₹8.52 Cr | ₹8.5 Cr |
| Total Income | ₹1,187.96 Cr | ₹1,060.41 Cr | ₹1,131.54 Cr | ₹1,049.17 Cr | ₹1,059.62 Cr | ₹1,066.2 Cr | ₹1,055.7 Cr | ₹1,033.91 Cr | ₹1,083.94 Cr | ₹975.18 Cr | ₹1,028.46 Cr | ₹1,083.52 Cr |
| Cost of Materials Consumed | ₹597.38 Cr | ₹510.38 Cr | ₹547.95 Cr | ₹448.91 Cr | ₹481.13 Cr | ₹525.41 Cr | ₹511.75 Cr | ₹531.99 Cr | ₹487.62 Cr | ₹501.13 Cr | ₹472.68 Cr | ₹578.91 Cr |
| Purchases of Stock-in-Trade | ₹44.39 Cr | ₹41.65 Cr | ₹30.6 Cr | ₹32.4 Cr | ₹32.19 Cr | ₹9.03 Cr | ₹8.19 Cr | ₹7.4 Cr | ₹13.39 Cr | ₹18.14 Cr | ₹14.11 Cr | ₹20.9 Cr |
| Changes in Inventories | -₹23.01 Cr | ₹4.03 Cr | ₹21.96 Cr | ₹38.13 Cr | ₹19.62 Cr | ₹4.19 Cr | -₹12.83 Cr | -₹10.8 Cr | ₹94.92 Cr | -₹10.67 Cr | ₹18.48 Cr | -₹49.59 Cr |
| Employee Benefit Expense | ₹106.28 Cr | ₹103.6 Cr | ₹107.5 Cr | ₹108.23 Cr | ₹96 Cr | ₹105.15 Cr | ₹112.7 Cr | ₹101.5 Cr | ₹85.94 Cr | ₹101.12 Cr | ₹103.45 Cr | ₹93.44 Cr |
| Finance Costs | ₹11.81 Cr | ₹12.46 Cr | ₹12.16 Cr | ₹12.69 Cr | ₹13.91 Cr | ₹12.39 Cr | ₹15.07 Cr | ₹14.27 Cr | ₹13.62 Cr | ₹15.06 Cr | ₹12.52 Cr | ₹11.46 Cr |
| Depreciation & Amortisation | ₹48.37 Cr | ₹45.04 Cr | ₹41.23 Cr | ₹40.84 Cr | ₹39.39 Cr | ₹39.76 Cr | ₹39.6 Cr | ₹38.88 Cr | ₹35.72 Cr | ₹34.24 Cr | ₹33.91 Cr | ₹32.3 Cr |
| Other Expenses | ₹291.01 Cr | ₹264.78 Cr | ₹277.2 Cr | ₹268.14 Cr | ₹275.63 Cr | ₹274.7 Cr | ₹300.86 Cr | ₹284.72 Cr | ₹301.33 Cr | ₹261.11 Cr | ₹293.56 Cr | ₹314.71 Cr |
| Total Expenses | ₹1,076.23 Cr | ₹981.94 Cr | ₹1,038.6 Cr | ₹949.34 Cr | ₹957.87 Cr | ₹970.63 Cr | ₹975.34 Cr | ₹967.96 Cr | ₹1,032.54 Cr | ₹920.13 Cr | ₹948.71 Cr | ₹1,002.13 Cr |
| Profit Before Exceptional Items & Tax | ₹111.73 Cr | ₹78.47 Cr | ₹92.94 Cr | ₹99.83 Cr | ₹101.75 Cr | ₹95.57 Cr | ₹80.36 Cr | ₹65.95 Cr | ₹51.4 Cr | ₹55.05 Cr | ₹79.75 Cr | ₹81.39 Cr |
| Exceptional Items | ₹0 | -₹13.04 Cr | ₹0 | ₹0 | ₹0 | ₹0 | -₹14 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹111.73 Cr | ₹65.43 Cr | ₹92.94 Cr | ₹99.83 Cr | ₹101.75 Cr | ₹95.57 Cr | ₹80.22 Cr | ₹65.95 Cr | ₹51.4 Cr | ₹55.05 Cr | ₹79.75 Cr | ₹81.39 Cr |
| Total Tax Expense | ₹25.27 Cr | ₹18.51 Cr | ₹23.39 Cr | ₹24.67 Cr | ₹27.73 Cr | ₹26.2 Cr | ₹21.22 Cr | ₹17.29 Cr | ₹22.1 Cr | ₹16.52 Cr | ₹22.38 Cr | ₹23.72 Cr |
| Net Profit | ₹86.44 Cr | ₹46.9 Cr | ₹69.47 Cr | ₹75.1 Cr | ₹74.05 Cr | ₹69.38 Cr | ₹59 Cr | ₹48.74 Cr | ₹29.25 Cr | ₹38.56 Cr | ₹57.49 Cr | ₹57.59 Cr |
| attributable to Owners | ₹86.44 Cr | ₹46.9 Cr | ₹69.47 Cr | ₹75.1 Cr | ₹74.05 Cr | ₹69.38 Cr | ₹59 Cr | ₹48.74 Cr | ₹29.25 Cr | ₹38.56 Cr | ₹57.49 Cr | ₹57.59 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Comprehensive Income | ₹2.14 Cr | ₹65 Lakh | ₹7.46 Cr | ₹10.07 Cr | ₹6 Cr | -₹7.35 Cr | ₹1.51 Cr | ₹1.62 Cr | ₹3.31 Cr | ₹77 Lakh | -₹42 Lakh | -₹15 Lakh |
| Total Comprehensive Income | ₹88.58 Cr | ₹47.55 Cr | ₹76.93 Cr | ₹85.17 Cr | ₹80.05 Cr | ₹62.03 Cr | ₹60.51 Cr | ₹50.36 Cr | ₹32.56 Cr | ₹39.33 Cr | ₹57.07 Cr | ₹57.44 Cr |
| EBITDA (computed) | ₹171.91 Cr | ₹135.97 Cr | ₹146.33 Cr | ₹153.36 Cr | ₹155.05 Cr | ₹147.72 Cr | ₹135.03 Cr | ₹119.1 Cr | ₹100.74 Cr | ₹104.35 Cr | ₹126.18 Cr | ₹125.15 Cr |
| Basic EPS | ₹5.47 | ₹2.97 | ₹4.40 | ₹4.75 | ₹4.69 | ₹4.39 | ₹3.73 | ₹3.08 | ₹1.85 | ₹2.44 | ₹3.64 | ₹3.63 |
| Diluted EPS | ₹5.39 | ₹2.97 | ₹4.40 | ₹4.75 | ₹4.64 | ₹4.39 | ₹3.73 | ₹3.08 | ₹1.85 | ₹2.43 | ₹3.64 | ₹3.63 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Speciality Chemicals | ₹603.67 Cr | ₹112.93 Cr | ₹2,954.02 Cr | ₹646.27 Cr |
| Nutrition & Health Solutions | ₹230.28 Cr | ₹25.79 Cr | ₹803.08 Cr | ₹146.86 Cr |
| Chemical Intermediates | ₹434.52 Cr | ₹5.51 Cr | ₹1,438.84 Cr | ₹530.17 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Speciality Chemicals | ₹2,214.26 Cr | ₹410.38 Cr | - | - |
| Nutrition & Health Solutions | ₹790.4 Cr | ₹79.42 Cr | - | - |
| Chemical Intermediates | ₹1,667.98 Cr | ₹18.91 Cr | - | - |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹4,138.49 Cr | ₹3,941.23 Cr | ₹3,987.25 Cr | ₹4,559.57 Cr | ₹4,860.42 Cr | ₹668.93 Cr |
| Other Income | ₹99.69 Cr | ₹81.01 Cr | ₹35.52 Cr | ₹31.03 Cr | ₹28.82 Cr | ₹2.45 Cr |
| Total Income | ₹4,238.18 Cr | ₹4,022.24 Cr | ₹4,022.77 Cr | ₹4,590.6 Cr | ₹4,889.24 Cr | ₹671.38 Cr |
| Cost of Materials Consumed | ₹2,154.57 Cr | ₹2,059.75 Cr | ₹2,039.05 Cr | ₹2,547.76 Cr | ₹2,798.18 Cr | ₹363.46 Cr |
| Purchases of Stock-in-Trade | ₹122.88 Cr | ₹56.68 Cr | ₹44.03 Cr | ₹113.43 Cr | ₹114.55 Cr | ₹14.52 Cr |
| Changes in Inventories | ₹21.04 Cr | -₹28.51 Cr | ₹66.88 Cr | -₹124.37 Cr | -₹90.89 Cr | ₹9.93 Cr |
| Employee Benefit Expense | ₹372.95 Cr | ₹376.07 Cr | ₹342.79 Cr | ₹305.88 Cr | ₹292.41 Cr | ₹43.11 Cr |
| Finance Costs | ₹56.62 Cr | ₹65.07 Cr | ₹66.29 Cr | ₹38.24 Cr | ₹46.24 Cr | ₹9.45 Cr |
| Depreciation & Amortisation | ₹161.18 Cr | ₹147.32 Cr | ₹133.14 Cr | ₹119.74 Cr | ₹120.13 Cr | ₹21.35 Cr |
| Other Expenses | ₹994.66 Cr | ₹1,002.5 Cr | ₹1,091.59 Cr | ₹1,222.34 Cr | ₹933.15 Cr | ₹141.08 Cr |
| Total Expenses | ₹3,883.9 Cr | ₹3,678.88 Cr | ₹3,783.77 Cr | ₹4,223.02 Cr | ₹4,213.77 Cr | ₹602.9 Cr |
| Profit Before Exceptional Items & Tax | ₹354.28 Cr | ₹343.36 Cr | ₹239 Cr | ₹367.58 Cr | ₹675.47 Cr | ₹68.48 Cr |
| Exceptional Items | -₹12.22 Cr | ₹0 | ₹0 | ₹0 | ₹0 | -₹12.94 Cr |
| Profit Before Tax | ₹342.06 Cr | ₹343.36 Cr | ₹239 Cr | ₹367.58 Cr | ₹675.47 Cr | ₹55.54 Cr |
| Total Tax Expense | ₹74.09 Cr | ₹79.94 Cr | ₹76.55 Cr | ₹114.17 Cr | ₹223.22 Cr | ₹16.95 Cr |
| Net Profit | ₹267.97 Cr | ₹263.42 Cr | ₹162.45 Cr | ₹253.41 Cr | ₹452.25 Cr | ₹38.59 Cr |
| Other Comprehensive Income | ₹15 Lakh | -₹2.1 Cr | -₹1.04 Cr | -₹94 Lakh | -₹1.11 Cr | -₹21 Lakh |
| Total Comprehensive Income | ₹268.12 Cr | ₹261.32 Cr | ₹161.41 Cr | ₹252.47 Cr | ₹451.14 Cr | ₹38.38 Cr |
| EBITDA (computed) | ₹572.08 Cr | ₹555.75 Cr | ₹438.43 Cr | ₹525.56 Cr | ₹841.84 Cr | ₹99.28 Cr |
| Basic EPS | ₹16.82 | ₹16.54 | ₹10.20 | ₹15.91 | ₹28.39 | ₹14.75 |
| Diluted EPS | ₹16.82 | ₹16.54 | ₹10.20 | ₹15.91 | ₹28.39 | ₹14.75 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹4,723.3 Cr | ₹4,520.72 Cr | ₹4,340.4 Cr | ₹4,058.39 Cr |
| Non-current Assets | ₹2,914.24 Cr | ₹2,863.62 Cr | ₹2,797.32 Cr | ₹2,461.21 Cr |
| Current Assets | ₹1,809.06 Cr | ₹1,657.1 Cr | ₹1,543.08 Cr | ₹1,597.18 Cr |
| Property, Plant & Equipment | ₹2,351.22 Cr | ₹2,318.33 Cr | ₹2,215.29 Cr | ₹1,698.37 Cr |
| Inventories | ₹732.56 Cr | ₹804.37 Cr | ₹775.32 Cr | ₹880.27 Cr |
| Trade Receivables | ₹688.79 Cr | ₹573.27 Cr | ₹563.22 Cr | ₹496.92 Cr |
| Cash & Equivalents | ₹164.67 Cr | ₹41.07 Cr | ₹18.7 Cr | ₹24.66 Cr |
| Equity (Net Worth) | ₹2,640.06 Cr | ₹2,440.88 Cr | ₹2,247.06 Cr | ₹2,158.57 Cr |
| Equity Share Capital | ₹15.93 Cr | ₹15.93 Cr | ₹15.93 Cr | ₹15.93 Cr |
| Borrowings (Non-current) | ₹260.76 Cr | ₹383.53 Cr | ₹395.57 Cr | ₹337.25 Cr |
| Borrowings (Current) | ₹485.78 Cr | ₹441.19 Cr | ₹433.68 Cr | ₹263.47 Cr |
| Total Debt (computed) | ₹746.54 Cr | ₹824.72 Cr | ₹829.25 Cr | ₹600.72 Cr |
| Current Liabilities | ₹1,527.7 Cr | ₹1,413.63 Cr | ₹1,388.09 Cr | ₹1,269.4 Cr |
| Total Liabilities | ₹2,083.24 Cr | ₹2,079.84 Cr | ₹2,093.34 Cr | ₹1,899.82 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹461.94 Cr | ₹441.34 Cr | ₹393.64 Cr | ₹445.64 Cr | ₹586.8 Cr |
| Investing Cash Flow | -₹108.23 Cr | -₹210.55 Cr | -₹463.67 Cr | -₹475.28 Cr | -₹220.76 Cr |
| Financing Cash Flow | -₹230.11 Cr | -₹208.42 Cr | ₹64.07 Cr | ₹32.8 Cr | -₹410.23 Cr |
| Capital Expenditure | ₹134.37 Cr | ₹216.26 Cr | ₹341.14 Cr | ₹446.04 Cr | ₹224.63 Cr |
| Free Cash Flow (computed) | ₹327.57 Cr | ₹225.08 Cr | ₹52.5 Cr | -₹40 Lakh | ₹362.17 Cr |
| Dividends Paid | ₹79.18 Cr | ₹79.52 Cr | ₹79.27 Cr | ₹79.47 Cr | ₹45.24 Cr |
| Net Change in Cash | ₹123.6 Cr | ₹22.37 Cr | -₹5.96 Cr | ₹3.16 Cr | -₹44.19 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,093.47 Cr | ₹1,018.01 Cr | ₹1,054.18 Cr | ₹973.08 Cr | ₹971.98 Cr | ₹994.77 Cr | ₹1,005.39 Cr | ₹969.09 Cr | ₹1,036.74 Cr | ₹916.7 Cr | ₹1,003.09 Cr | ₹1,030.72 Cr |
| Other Income | ₹46.03 Cr | ₹31.88 Cr | ₹10.91 Cr | ₹11.1 Cr | ₹35.6 Cr | ₹27.22 Cr | ₹8.97 Cr | ₹9.22 Cr | ₹9.77 Cr | ₹8.11 Cr | ₹8.03 Cr | ₹9.61 Cr |
| Total Income | ₹1,139.5 Cr | ₹1,049.89 Cr | ₹1,065.09 Cr | ₹984.18 Cr | ₹1,007.58 Cr | ₹1,021.99 Cr | ₹1,014.36 Cr | ₹978.31 Cr | ₹1,046.51 Cr | ₹924.81 Cr | ₹1,011.12 Cr | ₹1,040.33 Cr |
| Cost of Materials Consumed | ₹597.22 Cr | ₹525.3 Cr | ₹556.56 Cr | ₹475.49 Cr | ₹496.37 Cr | ₹527.44 Cr | ₹505.62 Cr | ₹530.32 Cr | ₹486.33 Cr | ₹501.13 Cr | ₹472.68 Cr | ₹578.91 Cr |
| Purchases of Stock-in-Trade | ₹28.56 Cr | ₹31.39 Cr | ₹30.53 Cr | ₹32.4 Cr | ₹32.06 Cr | ₹9.03 Cr | ₹8.19 Cr | ₹7.4 Cr | ₹8.32 Cr | ₹14.37 Cr | ₹7.99 Cr | ₹13.35 Cr |
| Changes in Inventories | -₹29.33 Cr | ₹10.7 Cr | ₹15.55 Cr | ₹24.12 Cr | -₹10.52 Cr | -₹12.93 Cr | -₹3.85 Cr | -₹1.21 Cr | ₹102.11 Cr | -₹12.2 Cr | ₹32.6 Cr | -₹55.63 Cr |
| Employee Benefit Expense | ₹91.79 Cr | ₹89.43 Cr | ₹95.12 Cr | ₹96.61 Cr | ₹86.25 Cr | ₹93.73 Cr | ₹101.77 Cr | ₹91.62 Cr | ₹76.56 Cr | ₹90.05 Cr | ₹92.53 Cr | ₹83.65 Cr |
| Finance Costs | ₹13.14 Cr | ₹14.55 Cr | ₹14.1 Cr | ₹14.83 Cr | ₹15.74 Cr | ₹15.33 Cr | ₹17.31 Cr | ₹16.69 Cr | ₹16.65 Cr | ₹18.46 Cr | ₹15.9 Cr | ₹15.28 Cr |
| Depreciation & Amortisation | ₹42.84 Cr | ₹41.58 Cr | ₹38.53 Cr | ₹38.23 Cr | ₹36.79 Cr | ₹37.18 Cr | ₹37.02 Cr | ₹36.33 Cr | ₹34.52 Cr | ₹33.64 Cr | ₹33.29 Cr | ₹31.69 Cr |
| Other Expenses | ₹267.52 Cr | ₹249.3 Cr | ₹255.24 Cr | ₹223.08 Cr | ₹239.94 Cr | ₹246.64 Cr | ₹265.8 Cr | ₹252.82 Cr | ₹269.59 Cr | ₹249.35 Cr | ₹276.35 Cr | ₹296.3 Cr |
| Total Expenses | ₹1,011.74 Cr | ₹962.25 Cr | ₹1,005.63 Cr | ₹904.76 Cr | ₹896.63 Cr | ₹916.42 Cr | ₹931.86 Cr | ₹933.97 Cr | ₹994.08 Cr | ₹894.8 Cr | ₹931.34 Cr | ₹963.55 Cr |
| Profit Before Exceptional Items & Tax | ₹127.76 Cr | ₹87.64 Cr | ₹59.46 Cr | ₹79.42 Cr | ₹110.95 Cr | ₹105.57 Cr | ₹82.5 Cr | ₹44.34 Cr | ₹52.43 Cr | ₹30.01 Cr | ₹79.78 Cr | ₹76.78 Cr |
| Exceptional Items | ₹0 | -₹12.22 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹127.76 Cr | ₹75.42 Cr | ₹59.46 Cr | ₹79.42 Cr | ₹110.95 Cr | ₹105.57 Cr | ₹82.5 Cr | ₹44.34 Cr | ₹52.43 Cr | ₹30.01 Cr | ₹79.78 Cr | ₹76.78 Cr |
| Total Tax Expense | ₹22.54 Cr | ₹15.71 Cr | ₹15.43 Cr | ₹20.41 Cr | ₹21.08 Cr | ₹24.97 Cr | ₹22.32 Cr | ₹11.57 Cr | ₹21.45 Cr | ₹10.68 Cr | ₹22.46 Cr | ₹21.96 Cr |
| Net Profit | ₹105.22 Cr | ₹59.71 Cr | ₹44.03 Cr | ₹59.01 Cr | ₹89.87 Cr | ₹80.6 Cr | ₹60.18 Cr | ₹32.77 Cr | ₹30.98 Cr | ₹19.33 Cr | ₹57.32 Cr | ₹54.82 Cr |
| Other Comprehensive Income | ₹25 Lakh | -₹45 Lakh | ₹87 Lakh | -₹52 Lakh | ₹1.85 Cr | -₹1.52 Cr | -₹2.17 Cr | -₹26 Lakh | ₹1.11 Cr | -₹72 Lakh | -₹1.2 Cr | -₹23 Lakh |
| Total Comprehensive Income | ₹105.47 Cr | ₹59.26 Cr | ₹44.9 Cr | ₹58.49 Cr | ₹91.72 Cr | ₹79.08 Cr | ₹58.01 Cr | ₹32.51 Cr | ₹32.09 Cr | ₹18.61 Cr | ₹56.12 Cr | ₹54.59 Cr |
| EBITDA (computed) | ₹183.74 Cr | ₹143.77 Cr | ₹112.09 Cr | ₹132.48 Cr | ₹163.48 Cr | ₹158.08 Cr | ₹136.83 Cr | ₹97.36 Cr | ₹103.6 Cr | ₹82.11 Cr | ₹128.97 Cr | ₹123.75 Cr |
| Basic EPS | ₹6.60 | ₹3.75 | ₹2.77 | ₹3.70 | ₹5.64 | ₹5.06 | ₹3.78 | ₹2.06 | ₹1.94 | ₹1.21 | ₹3.60 | ₹3.44 |
| Diluted EPS | ₹6.60 | ₹3.75 | ₹2.77 | ₹3.70 | ₹5.64 | ₹5.06 | ₹3.78 | ₹2.06 | ₹1.94 | ₹1.21 | ₹3.60 | ₹3.44 |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Speciality Chemicals | ₹575.29 Cr | ₹153.98 Cr | ₹2,323.16 Cr | ₹426.59 Cr |
| Nutrition & Health Solutions | ₹193.96 Cr | ₹8.64 Cr | ₹614.93 Cr | ₹153 Cr |
| Chemical Intermediates | ₹414.04 Cr | -₹1.55 Cr | ₹1,248.96 Cr | ₹550.25 Cr |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Speciality Chemicals | ₹2,139.92 Cr | ₹477.89 Cr | - | - |
| Nutrition & Health Solutions | ₹722.61 Cr | ₹30.37 Cr | - | - |
| Chemical Intermediates | ₹1,560.53 Cr | -₹21.73 Cr | - | - |
Shareholding Pattern of Jubilant Ingrevia Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 45.22%, foreign institutional investors hold 6.49%, domestic institutional investors hold 24.76%, retail and other public shareholders hold 22.52% of Jubilant Ingrevia Limited. The company had 112,696 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 45.22% | 45.22% | 45.22% | 45.22% | 51.47% | 51.47% |
| Public | 53.79% | 53.98% | 53.95% | 54.06% | 47.80% | 47.79% |
| Employee Trusts | 0.98% | 0.80% | 0.82% | 0.72% | 0.73% | 0.74% |
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|---|
| Promoters | 45.22% | 51.47% | 51.47% | 51.47% | 51.10% | 50.68% |
| Public | 53.79% | 47.80% | 47.72% | 48.33% | 48.70% | 49.32% |
| Employee Trusts | 0.98% | 0.73% | 0.81% | 0.19% | 0.20% | 0.00% |
| Promoter change (YoY, %pts) | -6.25 | +0.00 | +0.00 | +0.37 | +0.42 | - |
Board & Governance of Jubilant Ingrevia Limited
As per the corporate governance filing with NSE for the quarter ended 31-DEC-2025, the board of Jubilant Ingrevia Limited has 12 directors - 6 independent and 3 executive. The board is chaired by SHYAM SUNDER BHARTIA.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| SHYAM SUNDER BHARTIA | Non-Executive - Non Independent Director · Chairperson | 2021-02-06 | 4 |
| HARI SHANKER BHARTIA | Executive Director | 2021-02-06 | 6 |
| SUDHA PILLAI | Non-Executive - Independent Director | 2021-02-06 | 3 |
| SUSHIL KUMAR ROONGTA | Non-Executive - Independent Director | 2021-02-06 | 6 |
| ARUN SETH | Non-Executive - Independent Director | 2021-02-06 | 4 |
| PRADEEP JYOTI BANERJEE | Non-Executive - Independent Director | 2021-02-06 | 4 |
| SIRAJ AZMAT CHAUDHRY | Non-Executive - Independent Director | 2021-02-06 | 3 |
| AMEETA CHATTERJEE | Non-Executive - Independent Director | 2021-04-17 | 2 |
| PRIYAVRAT BHARTIA | Non-Executive - Non Independent Director | 2021-02-06 | 6 |
| VIJAY KUMAR SRIVASTAVA | Executive Director | 2024-11-01 | 1 |
| DEEPAK JAIN | Executive Director · CEO-MD | 2023-10-01 | 1 |
| Aashti Bhartia | Non-Executive - Non Independent Director | 2025-08-01 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | SUSHIL KUMAR ROONGTA (Chairperson), ARUN SETH, PRADEEP JYOTI BANERJEE, SIRAJ AZMAT CHAUDHRY, AMEETA CHATTERJEE |
| Nomination and remuneration committee | PRADEEP JYOTI BANERJEE (Chairperson), SHYAM SUNDER BHARTIA, SUDHA PILLAI, SIRAJ AZMAT CHAUDHRY, AMEETA CHATTERJEE |
| Stakeholders Relationship Committee | SIRAJ AZMAT CHAUDHRY (Chairperson), SUSHIL KUMAR ROONGTA, ARUN SETH, DEEPAK JAIN |
| Risk Management Committee | ARUN SETH (Chairperson), SUDHA PILLAI, SUSHIL KUMAR ROONGTA, PRADEEP JYOTI BANERJEE, SIRAJ AZMAT CHAUDHRY, AMEETA CHATTERJEE, PRIYAVRAT BHARTIA, Aashti Bhartia, DEEPAK JAIN, Varun Gupta |
| Corporate Social Responsibility Committee | SUDHA PILLAI (Chairperson), ARUN SETH, SUSHIL KUMAR ROONGTA, PRADEEP JYOTI BANERJEE, AMEETA CHATTERJEE, PRIYAVRAT BHARTIA, Aashti Bhartia, DEEPAK JAIN |
Group Structure of Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has 2 subsidiary companies and 2 associated companies. This group structure data is as of FY 2022. The corporate group structure reflects Jubilant Ingrevia Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Jubilant Agro Sciences Limited | U24100UP2021PLC146803 | - |
| Jubilant Infrastructure Limited | U45201UP2006PLC031618 | - |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Jubilant Ingrevia Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2024 | Hdfc Bank Limited | ₹120 Cr | Open |
| 14 Feb 2024 | Hdfc Bank Limited | ₹150 Cr | Open |
| 29 Mar 2023 | Axis Bank Limited | ₹150 Cr | Open |
| 30 Mar 1999 | Others | ₹1,800 Cr | Open |
| 20 Nov 2020 | Others | ₹100 Cr | Satisfied |
Total charge records: 6 View all charges
Employees and EPFO Compliance at Jubilant Ingrevia Limited
Jubilant Ingrevia Limited has a workforce of 2,186 employees as of Jun 19, 2024.
Employee Count & EPFO Data of Jubilant Ingrevia Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Jubilant Ingrevia Limited
GSTIN & GST Filing Data of Jubilant Ingrevia Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Jubilant Ingrevia Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Jubilant Ingrevia Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Jubilant Ingrevia Limited
MSME Payment Delays by Jubilant Ingrevia Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Jubilant Ingrevia Limited
Subsidiaries & Group Companies of Jubilant Ingrevia Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Jubilant Ingrevia Limited with ownership details.
MCA Filings & Documents of Jubilant Ingrevia Limited
MCA Filings & Documents of Jubilant Ingrevia Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Jubilant Ingrevia Limited
Recent News on Jubilant Ingrevia Limited
Frequently Asked Questions about Jubilant Ingrevia Limited
Jubilant Ingrevia Limited is an active public limited company in the chemicals and materials sector based in District Amroha, Uttar Pradesh, India. It was incorporated on 23 October 2019 (7+ years old) and is registered under CIN L24299UP2019PLC122657. Listed on BSE: 543271 and NSE: JUBLINGREA. The company has 2,186 employees.
Jubilant Ingrevia Limited reported revenue of ₹4,215.43 Cr for FY 2025 (up 1.00% YoY).
The current directors of Jubilant Ingrevia Limited are:
The primary industry of Jubilant Ingrevia Limited is chemicals and materials. The company specifically operates in industrial chemicals. The company is currently active in this sector.
Yes. Jubilant Ingrevia Limited is listed on both BSE (code: 543271) and NSE (symbol: JUBLINGREA).
Jubilant Ingrevia Limited can be reached at the registered office: Bhartiagram Gajraula, District Amroha, Uttar Pradesh, India – 244223, or through the website jubilantingrevia.com.